Another study by the same group, involving 38 patients with ischemic cardiomyopathy, showed that PTX significantly improved LVEF and reduced inflammatory markers such as TNF-α and C-reactive protein (CRP) [43]. This evidence concerns the gene CRP and ischemic cardiomyopathy.